Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Timothy G, Call"'
Autor:
Isla M. Johnson, Caleb Scheckel, Sameer A. Parikh, Mark Enzler, Jennifer Fugate, Timothy G. Call
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 10, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/1b44e0f86ec7403b9936817624b002c9
Autor:
Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-6 (2022)
Abstract Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to toxicity. A better understanding of expected outcomes in these patients is necessary to
Externí odkaz:
https://doaj.org/article/c5ee38417b3b4e7f8218d469cd1ba54f
Autor:
Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas J. Boddicker, Janet E. Olson, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Susan L. Slager, Tait D. Shanafelt
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/84ef60e8cb4d400eaa21e2c7b68110e9
Autor:
Rebecca L. King, Alia Gupta, Paul J. Kurtin, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Susan M. Schwager, Susan L. Slager, Neil. E. Kay, Amber Koehler, Stephen M. Ansell, David J. Inwards, Thomas M. Habermann, Min Shi, Curtis A. Hanson, Matthew T. Howard, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The distinction between chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with isolated Hodgkin/Reed–Sternberg cells (CLL-HRS; background milieu with a paucity of inflammatory cells) and overt transformation to classic Hodg
Externí odkaz:
https://doaj.org/article/989c3e3359c44e3abd2c16b6d6766da6
Autor:
Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/863bb1613c0f4313b4f20f6c1c59d34d
Autor:
Yucai Wang, Sutapa Sinha, Linda E. Wellik, Charla R. Secreto, Karen L. Rech, Timothy G. Call, Sameer A. Parikh, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Daniel L. Van Dyke, Jose F. Leis, Susan L. Slager, Haidong Dong, Neil E. Kay, Rong He, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-9 (2021)
Abstract Richter syndrome (RS) refers to transformation of chronic lymphocytic leukemia (CLL) to an aggressive lymphoma, most commonly diffuse large B-cell lymphoma. RS is known to be associated with a number of genetic alterations such as TP53 and N
Externí odkaz:
https://doaj.org/article/6b326bb24b624e97b5dc1e2dce130e5f
Autor:
Shulan Tian, Henan Zhang, Pan Zhang, Michael Kalmbach, Jeong-Heon Lee, Tamas Ordog, Paul J. Hampel, Timothy G. Call, Thomas E. Witzig, Neil E. Kay, Eric W. Klee, Susan L. Slager, Huihuang Yan, Wei Ding
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract T cell prolymphocytic leukemia (T-PLL) is a rare disease with aggressive clinical course. Cytogenetic analysis, whole-exome and whole-genome sequencing have identified primary structural alterations in T-PLL, including inversion, translocati
Externí odkaz:
https://doaj.org/article/43304e766b734189afed60f90539ff6d
Autor:
Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun V. Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Min Shi, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-6 (2021)
Externí odkaz:
https://doaj.org/article/5034355e2436472d9133161b489aabbc
Autor:
Sutapa Sinha, Charla R. Secreto, Justin C. Boysen, Connie Lesnick, Zhiquan Wang, Wei Ding, Timothy G. Call, Saad J. Kenderian, Sameer A. Parikh, Steven L. Warner, David J. Bearss, Asish K. Ghosh, Neil E. Kay
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-6 (2021)
Externí odkaz:
https://doaj.org/article/75b67ecc247f48d9a9eb3670ad8a650c
Autor:
Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call, Kari G. Rabe, Wei Ding, Jose F. Leis, Saad S. Kenderian, Asher A. Chanan‐Khan, Amber B. Koehler, Susan M. Schwager, Eli Muchtar, Amie L. Fonder, Kristen B. McCullough, Adrienne N. Nedved, Matthew D. Smith, Susan L. Slager, Neil E. Kay, Heidi D. Finnes, Tait D. Shanafelt
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3390-3399 (2020)
Abstract To study the impact of dose modification and temporary interruption of ibrutinib in routine clinical practice, we conducted a retrospective study of consecutive CLL patients treated with ibrutinib outside the context of a clinical trial at M
Externí odkaz:
https://doaj.org/article/ec5898c07904452d8346728e1b2de5a5